Organogenesis Holdings (ORGO) EBT Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) EBT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn | -329.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -329.95% |
| Mar 31, 2026 | -165.57% |
| Dec 31, 2025 | 518.62% |
| Sep 30, 2025 | 263.39% |
| Jun 30, 2025 | 18.61% |
| Mar 31, 2025 | -493.67% |
| Dec 31, 2024 | 670.88% |
| Sep 30, 2024 | -23.75% |
| Jun 30, 2024 | -258.41% |
| Mar 31, 2024 | 6.14% |
| Dec 31, 2023 | -120.52% |
| Sep 30, 2023 | 530.12% |
| Jun 30, 2023 | -17.93% |
| Mar 31, 2023 | -433.06% |
| Dec 31, 2022 | -53.66% |
| Sep 30, 2022 | -90.59% |
| Jun 30, 2022 | -47.18% |
| Mar 31, 2022 | -108.56% |
| Dec 31, 2021 | 0.95% |
| Sep 30, 2021 | -38.16% |